Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NADROPARIN vs NALMEFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NADROPARIN vs NALMEFENE: Safety Overview

Metric NADROPARIN NALMEFENE
Total FAERS Reports 676 197
Deaths Reported 57 77
Death Rate 8.4% 39.1%
Hospitalizations 355 118
Average Patient Age 56.3 yrs 44.2 yrs
% Female Patients 58.5% 39.3%
FDA Approval Date N/A Apr 17, 1995
Manufacturer N/A Purdue Pharma L.P.
Route N/A INTRAMUSCULAR
Marketing Status N/A Discontinued